Back to search

CYTOMEGALOVIRUS PROPHYLAXIS IN SOLID ORGAN TRANSPLANT RECIPIENTS

Data up to Jan 2025

Published1996
Citations200
References43
Clinical Trials (1)

Total Citations Per Year

Abstract

References (43)

Use of Cytomegalovirus Immune Globulin to Prevent Cytomegalovirus Disease in Renal-Transplant Recipients

1987 • 576 citations

A Randomized, Placebo-Controlled Trial of Oral Acyclovir for the Prevention of Cytomegalovirus Disease in Recipients of Renal Allografts

1989 • 548 citations

Acyclovir for Prevention of Cytomegalovirus Infection and Disease after Allogeneic Marrow Transplantation

1988 • 456 citations

Human cytomegalovirus UL97 open reading frame encodes a protein that phosphorylates the antiviral nucleoside analogue ganciclovir

1992 • 394 citations

A Controlled Trial of Ganciclovir to Prevent Cytomegalovirus Disease after Heart Transplantation

1992 • 384 citations

Hepatitis C Infection in Patients with Primary Hypogammaglobulinemia after Treatment with Contaminated Immune Globulin

1994 • 380 citations

Preemptive Ganciclovir Therapy To Prevent Cytomegalovirus Disease in Cytomegalovirus Antibody-Positive Renal Transplant Recipients

1995 • 252 citations

Cytomegalovirus Immune Globulin Prophylaxis in Liver Transplantation

1993 • 206 citations

Effect of Towne Live Virus Vaccine on Cytomegalovirus Disease after Renal Transplant

1991 • 201 citations

High-Dose Acyclovir Compared with Short-Course Preemptive Ganciclovir Therapy To Prevent Cytomegalovirus Disease in Liver Transplant Recipients

1994 • 189 citations

A comparison of ganciclovir and acyclovir to prevent cytomegalovirus after lung transplantation.

1994 • 157 citations

OKT3 Treatment for Allograft Rejection Is a Risk Factor for Cytomegalovirus Disease in Liver Transplantation

1995 • 142 citations

Antigenemia in the Diagnosis and Monitoring of Active Cytomegalovirus Infection after Liver Transplantation

1991 • 137 citations

Cytomegalovirus Infection Persists in the Liver Graft in the Vanishing Bile Duct Syndrome

1992 • 122 citations

Reducing the Risk for Transfusion-transmitted Cytomegalovirus Infection

1992 • 118 citations

A PROSPECTIVE RANDOMIZED TRIAL COMPARING SEQUENTIAL GANCICLOVIR-HIGH DOSE ACYCLOVIR TO HIGH DOSE ACYCLOVIR FOR PREVENTION OF CYTOMEGALOVIRUS DISEASE IN ADULT LIVER TRANSPLANT RECIPIENTS

1994 • 113 citations

Low predictive value of polymerase chain reaction for diagnosis of cytomegalovirus disease in liver transplant recipients

1992 • 113 citations

Interactions of Cytomegalovirus with the Human Immune System

1988 • 110 citations

Pharmacokinetic, Safety, and Antiviral Profiles of Oral Ganciclovir in Persons Infected with Human Immunodeficiency Virus: A Phase I/II Study

1995 • 107 citations

A Randomized Prospective Trial of Acyclovir and Immune Globulin Prophylaxis in Liver Transplant Recipients Receiving OKT3 Therapy

1992 • 95 citations

Antimicrobial strategies in the care of organ transplant recipients

1993 • 93 citations

Cytomegalovirus antigenemia: clinical correlations in transplant recipients and in persons with AIDS

1993 • 85 citations

A PROSPECTIVE RANDOMIZED STUDY OF ACYCLOVIR VERSUS GANCICLOVIR PLUS HUMAN IMMUNE GLOBULIN PROPHYLAXIS OF CYTOMEGALOVIRUS INFECTION AFTER SOLID ORGAN TRANSPLANTATION1,2

1994 • 82 citations

Ganciclovir Susceptibilities of Cytomegalovirus (CMV) Isolates from Solid Organ Transplant Recipients with CMV Viremia after Antiviral Prophylaxis

1993 • 76 citations

THE CORRELATION BETWEEN SYMPTOMATIC CMV INFECTION AND CMV ANTIGENEMIA IN HEART ALLOGRAFT RECIPIENTS

1993 • 66 citations

Detection of cytomegalovirus DNA in sera of liver transplant recipients

1994 • 66 citations

SEQUENTIAL THERAPY—A PROSPECTIVE RANDOMIZED TRIAL OF MALG VERSUS OKT3 FOR PROPHYLACTIC IMMUNOSUPPRESSION IN CADAVER RENAL ALLOGRAFT RECIPIENTS

1992 • 64 citations

Protection Against Murine Cytomegalovirus Infection by Passive Transfer of Neutralizing and Non-Neutralizing Monoclonal Antibodies

1991 • 62 citations

THE PROGNOSTIC SIGNIFICANCE OF POSITIVE CMV CULTURES DURING SURVEILLANCE OF RENAL TRANSPLANT RECIPIENTS

1993 • 57 citations

Effect of prophylactic ganciclovir on cytomegalovirus infection in renal transplant recipients

1993 • 54 citations

Use of immune globulin to prevent symptomatic cytomegalovirus disease in transplant recipients--a meta-analysis.

1994 • 52 citations

PREVENTION OF CYTOMEGALOVIRUS-RELATED DEATH BY PASSIVE IMMUNIZATION

1989 • 51 citations

Formulation Of An Immunogenic Human Cytomegalovirus Vaccine: Responses In Mice

1995 • 50 citations

Therapeutic Reconstitution of Human Viral Immunity by Adoptive Transfer of Cytotoxic T Lymphocyte Clones

1994 • 47 citations

Controlled trial of prophylactic versus therapeutic use of ganciclovir after liver transplantation in adults

1993 • 45 citations

Transmission of Cytomegalovirus by Pretransplant Leukocyte Transfusions in Renal Transplant Candidates

1987 • 44 citations

WHICH RENAL TRANSPLANT PATIENTS SHOULD RECEIVE CYTOMEGALOVIRUS IMMUNE GLOBULIN?

1991 • 43 citations

Prospective randomized trial of efficacy of ganciclovir versus that of anti-cytomegalovirus (CMV) immunoglobulin to prevent CMV disease in CMV-seropositive heart transplant recipients treated with OKT3

1995 • 41 citations

Semiquantitative Measurement of Cytomegalovirus DNA in Lung and Heart-Lung Transplant Patients by in Vitro DNA Amplification

1992 • 40 citations

Failure of high-dose oral acyclovir with or without immune globulin to prevent primary cytomegalovirus disease in recipients of solid organ transplants

1993 • 38 citations

Polyvalent Immune Globulin and Cytomegalovirus Infection After Renal Transplantation

1989 • 29 citations

Evaluation of SQ 34,514: pharmacokinetics and efficacy in experimental herpesvirus infections in mice

1991 • 26 citations

Los Angeles County's hospitals dilemma

1995 • 4 citations

Cited By (0)

No citing papers found in database

CYTOMEGALOVIRUS PROPHYLAXIS IN SOLID ORGAN TRANSPLANT RECIPIENTS (1996) – Transplantation | Metascience Observatory Explorer